Cat No:BIOK-0002
Our standard bioink is a synthetic peptide hydrogel bioink that constructs a nanofibrous network, effectively replicating the extracellular matrix. Tailored specifically for bioprinting and advanced 3D cell culture applications, this bioink stands out for its biocompatibility and adaptability. Its mechanical properties can be fine-tuned to accommodate a diverse range of printing applications, offering unparalleled versatility.
| 3D cell culture for regenerative medicine. Modeling tissue microenvironments for drug screening. Biomimetic scaffolds for neural, cartilage, and vascular tissues. |
| The bioink, when prepared as recommended, yields a printable material that can create mechanically robust 3D structures. Nonetheless, users have the flexibility to adjust the preparation process according to their specific requirements and printer type. Consistent Quality: Ensures no variation between batches, guaranteeing reproducibility in every use. Adjustable Mechanical Properties: Allows for precise tuning of mechanical characteristics to meet diverse printing needs. Superior Printability: Exhibits excellent printability at room temperature, simplifying the printing process. Temperature and pH-Independent Gelation: The gelation process is not influenced by temperature or pH, providing greater control and stability. |
| Storage | The product is shipped as lyophilised powder at room temperature and should be stored in a freezer at -20°C until ready to rehydrate. The product is stable up to 12 months when stored under these conditions. |
| Type | Hydrogels |
| Size | 250 mg + 10ml glass bottle |
Eata 3DPrint: Your innovation partner for advanced 3D printing solutions, delivering cutting-edge services and materials to transform industries and drive progress.
For Research or Industrial Raw Materials, Not For Personal Medical Use!
|
There is no product in your cart. |
Eata 3DPrint: Your innovation partner for advanced 3D printing solutions, delivering cutting-edge services and materials to transform industries and drive progress.
Enter your E-mail and receive the latest news from us.
